Aslan raises $23M in pre-IPO round

Cancer biotech Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $23 million in a

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE